Ziltivekimab
4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Ziltivekimab for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Ziltivekimab for coronary artery disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ziltivekimab for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ziltivekimab for renal insufficiency, chronic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |